acc017
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 24, 2024 (NCT06278389)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06719310 | Phase 1/Phase 2 (Phase 2) | Aug 28, 2024 | Capital Medical University, Jiangsu Aidea Pharmaceutical Co., Ltd |
| NCT06278389 | Phase 1 | Jan 24, 2024 | Capital Medical University, Jiangsu Aidea Pharmaceutical Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 0 | 2 | 2024 |
| Jiangsu Aidea Pharmaceutical Co., Ltd | For profit | 2 | 2 | 2 | 2024 |
2 organizations
Page 1 / 1